Literature DB >> 9293400

Study of interaction between L-glutamate and human blood lymphocytes.

I A Kostanyan1, M I Merkulova, E V Navolotskaya, R I Nurieva.   

Abstract

The presence of specific glutamate receptors on T lymphocytes separated from normal human blood was investigated. Upon study of T lymphocytes interaction with [3H]glutamate the last one was found to bind specifically to these cells, Kd = 2.36 x 10(-7) M. Thirteen unlabelled compounds were tested as potential glutamate competitors. It was shown that only quisqualate (a structural analogue of glutamate) and dipeptides Ala-Glu, Glu-Ala, Glu-Glu competed with [3H]glutamate in binding to a common binding site. The experiments on binding of labelled and unlabelled glutamate bulky conjugates with dextran have demonstrated that both conjugated and free glutamate interacted with the common binding sites on the outer cell membrane. By this means it was shown that T lymphocytes exposed quisqualate-sensitive glutamate receptors on the outer surface of the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9293400     DOI: 10.1016/s0165-2478(97)00086-2

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  9 in total

1.  Chapter 9 The dorsal horn and hyperalgesia.

Authors:  Karin N Westlund
Journal:  Handb Clin Neurol       Date:  2006

2.  Neurotransmitter signalling via NMDA receptors leads to decreased T helper type 1-like and enhanced T helper type 2-like immune balance in humans.

Authors:  Kanami Orihara; Solomon O Odemuyiwa; William P Stefura; Ramses Ilarraza; Kent T HayGlass; Redwan Moqbel
Journal:  Immunology       Date:  2017-11-03       Impact factor: 7.397

3.  Characterization of ionotropic glutamate receptors in human lymphocytes.

Authors:  G Lombardi; C Dianzani; G Miglio; P L Canonico; R Fantozzi
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

Review 4.  Glutamate, T cells and multiple sclerosis.

Authors:  Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2017-02-24       Impact factor: 3.575

Review 5.  The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.

Authors:  Yonatan Ganor; Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2014-03-02       Impact factor: 3.575

6.  The glutamate agonist NMDA blocks gonadal regression and enhances antibody response to an immune challenge in Siberian hamsters (Phodopus sungorus).

Authors:  Timothy J Greives; Susannah S French; Devin A Zysling; Nicholas W Garcia; Gregory E Demas
Journal:  J Comp Physiol B       Date:  2009-10-10       Impact factor: 2.200

7.  Medial Septal NMDA Glutamate Receptors are Involved in Modulation of Blood Natural Killer Cell Activity in Rats.

Authors:  Magdalena Podlacha; Wojciech Glac; Magdalena Listowska; Beata Grembecka; Irena Majkutewicz; Dorota Myślińska; Karolina Plucińska; Grażyna Jerzemowska; Maria Grzybowska; Danuta Wrona
Journal:  J Neuroimmune Pharmacol       Date:  2015-10-10       Impact factor: 4.147

8.  Group I mGlu receptor stimulation inhibits activation-induced cell death of human T lymphocytes.

Authors:  Annalisa Chiocchetti; Gianluca Miglio; Riccardo Mesturini; Federica Varsaldi; Marco Mocellin; Elisabetta Orilieri; Chiara Dianzani; Roberto Fantozzi; Umberto Dianzani; Grazia Lombardi
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

Review 9.  Critical Neurotransmitters in the Neuroimmune Network.

Authors:  Thomas Wesley Hodo; Maria Teresa Prudente de Aquino; Akiko Shimamoto; Anil Shanker
Journal:  Front Immunol       Date:  2020-08-21       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.